PRC2の損失はRas駆動の転写を拡大し,BRD4ベースの治療法に対する感受性を高めます
Thomas De Raedt1, Eline Beert2, Eric Pasmant3
11] Genetics Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [2] Harvard Medical School, Boston, Massachusetts 02115, USA [3] Ludwig Center at Dana-Farber/Harvard Cancer Center, Boston, Massachusetts 02115, USA.
Nature
|August 15, 2014
まとめ
ポリコンブ抑制複合体2 (PRC2) 遺伝子のSUZ12は,NF1変異と協力することによって,特定の癌の腫瘍抑制剤として作用します. SUZ12の喪失は,これらのがんをエピジェネティック療法に敏感にし,新しい治療戦略を明らかにします.
科学分野:
- 腫瘍学 腫瘍学
- エピジェネティクス エピジェネティクス
- 分子生物学は分子生物学である.
背景:
- ポリコンブ抑制複合体2 (PRC2) は,がんにおいて二重の役割を果たしており,一部の腫瘍において腫瘍性効果があり,他の腫瘍において機能喪失変異によって示唆される腫瘍抑制作用を有する.
- Ras GTPase活性化タンパク質 (RasGAP) をコードするNF1の変異は,Ras経路の活性化につながり,がんの発症を誘発します.
研究 の 目的:
- 癌におけるポリコンブグループ遺伝子SUZ12の役割,特にNF1変異との関連を調査する.
- SUZ12の減少が癌の進行に影響するメカニズムを明らかにし,潜在的な治療上の脆弱性を特定する.
主な方法:
- ゲノム解析ゲノム解析について
- 細胞アッセイ 細胞アッセイ
- マウスモデリング
- クロマチンの分析
主要な成果:
- SUZ12は,NF1変異と協力する際に,外周神経 (PNS) 腫瘍,高度の膠質腫,およびメラノーマにおける腫瘍抑制剤として機能する.
- SUZ12の喪失は,染色体に影響を与えることで,Ras駆動の転写を拡大し,それによってNF1変異の効果を強める.
- SUZ12不活性化は,これらのがんをブロモドメイン阻害剤に敏感にするエピジェネティックスイッチを誘発します.
結論:
- SUZ12は,NF1.1経由でRas経路と相互作用することによって,特定の癌において腫瘍抑制的な役割を果たします.
- この発見は,がんにおけるPRC2,NF1,Rasシグナル伝達との新しい関連性を明らかにしています.
- SUZ12不活性化は,ブロモドメイン阻害剤の使用を通じて,様々ながん,特にNF1変異を有するがんに対する有望な表遺伝子治療標的を提示します.
関連する概念動画
02:38The Ras Gene
5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
5.7K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
01:20The Retinoblastoma Gene
3.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
02:23Master Transcription Regulators
6.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
01:07MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
01:23Negative Regulator Molecules
32.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K